Lai Tsung-Hsuan, Chang Fung-Wei, Lin Jun-Jie, Ling Qing-Dong
Department of Obstetrics and Gynecology, Cathay General Hospital, Taipei, Taiwan; School of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan; Institute of Systems Biology and Bioinformatics, National Central University, Taoyuan City, Taiwan.
Tri-Service General Hospital Penghu Branch, National Defense Medical Center, Taipei, Taiwan; Department of Obstetrics and Gynecology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Taiwan J Obstet Gynecol. 2018 Aug;57(4):507-516. doi: 10.1016/j.tjog.2018.06.005.
Defects in L-selectin ligand (LSL) expression have been reported to cause implantation failure, but little is known about LSL expression in adenomyosis. This study evaluates LSL expression throughout the menstrual cycle in women with adenomyosis.
Endometrial samples were obtained from reproductive-aged women with adenomyosis who underwent hysterectomy. A total of 42 endometrial biopsies were included. There were 12 women in proliferative phase, 10 in early-secretory phase, 9 in mid-secretory phase, and 11 in late-secretory phase. Immunohistochemistry, western blotting, and RT-PCR were performed to evaluate LSL expression. A non-parametric Kruskal-Wallis one-way analysis of variance with multiple comparisons was performed to examine differences among menstrual phases.
Immunohistochemistry analysis with MECA-79 shows that LSL is expressed with weak intensity in the endometrium in all phases. In the luminal epithelium, MECA-79 reactivity increased from the proliferative to the late-secretory phase but decreased in the mid-secretory phase. There were significant differences in the mean histological scores (HSCOREs) among the proliferative, early-secretory, and late-secretory phases (p < 0.05). Five LSL genes were detected in the adenomyotic endometria: PODXL, EMCN, CD300LG, GLYCAM1, and CD34. The mRNA expression of LSL genes occurred differentially among phases. Moreover, PODXL differed significantly among phases (p < 0.05).
LSL expressions were downregulated in the luminal epithelium of adenomyotic endometria in the mid-secretory phase. The mRNA expressions of LSL genes also had differential expression patterns throughout the menstrual cycle, especially for PODXL. Our study showed that adenomyosis may cause abnormalities of LSL production in the mid-secretory phase, which may contribute to impaired endometrial receptivity and implantation failure.
据报道,L-选择素配体(LSL)表达缺陷会导致植入失败,但关于子宫腺肌病中LSL的表达情况知之甚少。本研究评估子宫腺肌病患者整个月经周期中的LSL表达。
从接受子宫切除术的生育年龄子宫腺肌病女性中获取子宫内膜样本。共纳入42例子宫内膜活检样本。其中增殖期12例,早分泌期10例,中分泌期9例,晚分泌期11例。采用免疫组织化学、蛋白质印迹法和逆转录-聚合酶链反应(RT-PCR)评估LSL表达。进行非参数Kruskal-Wallis单因素方差分析及多重比较,以检验各月经周期阶段之间的差异。
用MECA-79进行免疫组织化学分析显示,LSL在各阶段的子宫内膜中均呈弱强度表达。在腔上皮中,MECA-79反应性从增殖期到晚分泌期增加,但在中分泌期降低。增殖期、早分泌期和晚分泌期的平均组织学评分(HSCOREs)存在显著差异(p<0.05)。在子宫腺肌病的子宫内膜中检测到5种LSL基因:血小板/内皮细胞黏附分子(PODXL)、内皮细胞黏附分子(EMCN)、CD300LG、6-硫酸软骨素(GLYCAM1)和CD34。LSL基因的mRNA表达在各阶段存在差异。此外,PODXL在各阶段之间存在显著差异(p<0.05)。
子宫腺肌病子宫内膜腔上皮在中分泌期LSL表达下调。LSL基因的mRNA表达在整个月经周期中也有不同的表达模式,尤其是PODXL。我们的研究表明,子宫腺肌病可能导致中分泌期LSL产生异常,这可能导致子宫内膜容受性受损和植入失败。